http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1308358-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6831b19bfc354357342f7c7da79fc162
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-43
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
filingDate 1988-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1992-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32497b102c96d7a79e4e8873e24bb19a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3f25610fff1192f8e85584102272207
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8941faa566945d28b0d54f976536625a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7852a73980890900ce9516d786543c51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a82bae5a02fd463ba7cebd687ff0a55d
publicationDate 1992-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-1308358-C
titleOfInvention Antibacterial lyophilized preparation
abstract Abstract: The present invention is directed to an antibacterial lyophilized preparation which comprises as an active ingredient aspoxicillin and a basic salt of aspoxicillin in a molar ratio of 1 : about 0.7 to 7 and optionally an alkali metal halide as a stabilizer and a method for preparing the same. The antibacterial lyophilized preparation rapidly dissolves in distilled water to give a stable solution which can be injected into patients for the treatment of various bacterial infectious diseases.
priorityDate 1987-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453375181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393644
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10176137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452910676
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447496508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12905357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415749239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18330682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234

Total number of triples: 40.